Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer

Annals of Surgical Oncology

Volumn 14, Issue 3, 2007, Pages 1136-1142

  Panici, Pierluigi Benedetti ^a   De Vivo, Antonio ^a   Bellati, Filippo ^a   Manci, Natalina ^a   Perniola, Giorgia ^a   Basile, Stefano ^a   Muzii, Ludovico ^b   Angioli, Roberto ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Platinum sensitive; Prognostic factors; Recurrent ovarian cancer; Secondary cytoreduction

Indexed keywords

PLATINUM;

ADENOCARCINOMA; ARTICLE; COLLOID CARCINOMA; CYSTADENOCARCINOMA; ENDOMETRIUM TUMOR; FEMALE; HUMAN; MIDDLE AGED; NEOPLASM; OBSERVATION; OVARY TUMOR; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; TUMOR RECURRENCE;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OBSERVATION; OVARIAN NEOPLASMS; PLATINUM; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 34250223484     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9273-8     Document Type: Article

References (28)

1. Jemal A, Tiwari RC, Murray T, et al. American Cancer Society Cancer statistics, 2004. CA Cancer J Clin 2004; 54:8-29. (Pubitemid 38443417)
2. Young JA, Garretson F, Westlake DL, Illig WP, Vogl SE. Intraperitoneal cisplatin with intravenous cyclophosphamide and doxorubicin for previously untreated stage III and IV ovarian carcinoma. Cancer Invest 1989; 7:565-70. (Pubitemid 20161621)
3. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003; 53:5-26. (Pubitemid 36163619)
4. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a metaanalysis. J Clin Oncol 2002; 20:1248-59. (Pubitemid 34177431)
5. Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975; 42:101-4.
6. Wharton JT, Herson J. Surgery for common epithelial tumors of the ovary. Cancer 1981; 48:582-9. (Pubitemid 11058760)
7. Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Elashoff RM. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol 1983; 61:413-20. (Pubitemid 13158699)
8. McGuire WP. High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors. Curr Probl Cancer 1998; 22:135-77.
9. Berek JS, Hacker NF, Lagasse LD, Poth T, Resnick B, Nieberg RK. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status. Obstet Gynecol 1984; 64:207-12. (Pubitemid 14096694)
10. Rubin SC, Randall TC, Armstrong KA, Chi DS, Hoskins WJ. Ten-year follow-up of ovarian cancer patients after secondlook laparotomy with negative findings. Obstet Gynecol 1999; 93:21-4.
11. Berek JS, Bertelsen K, du Bois A, et al. Advanced epithelial ovarian cancer: 1998 consensus statements. Ann Oncol 1999; 10:87-92.
12. Eisenkop SM, Friedman RL, Spirtos NM. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 2000; 88:144-53. (Pubitemid 30027690)
13. Zang RY, Li ZT, Tang J, et al. Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits? Cancer 2004; 100:1152-61. (Pubitemid 38325942)
14. Petterson F. International Federation of Gynecology and Obstetrics Report. Stockholm: International Federation of Gynecology and Obstetrics, 1988; 110-51.
15. Berek JS, Hacker NF, Lagasse LD, Nieberg RK, Elashoff RM. Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol 1983; 61:189-93. (Pubitemid 13110698)
16. Morris M, Gershenson DM, Wharton JT, Copeland LJ, Edwards CL, Stringer CA. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Gynecol Oncol 1989; 34:334-8. (Pubitemid 19218573)
17. Janicke F, Holscher M, Kuhn W, et al. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer 1992; 70:2129-36.
18. Segna RA, Dottino PR, Mandeli JP, Konsker K, Cohen CJ. Secondary cytoreduction for ovarian cancer following cisplatin therapy. Clin Oncol 1993; 11:434-9. (Pubitemid 23071038)
19. Vaccarello L, Rubin SC, Vlamis V, et al. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol Oncol 1995; 57:61-5.
20. Gadducci A, Iacconi P, Cosio S, Fanucchi A, Cristofani R, Riccardo Genazzani A. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gynecol Oncol 2000; 79:344-9.
21. Munkarah A, Levenback C, Wolf JK, et al. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer. Gynecol Oncol 2001; 81:237-41. (Pubitemid 32424168)
22. Scarabelli C, Gallo A, Carbone A. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol 2001; 83:504-12. (Pubitemid 33139711)
23. Tay EH, Grant PT, Gebski V, Hacker NF. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Obstet Gynecol. 2002; 99:1008-13. (Pubitemid 34621223)
24. Pfisterer J, Harter P, Canzler U, et al. The role of surgery in recurrent ovarian cancer. Int J Gyn Cancer 2005; 15:195-198. (Pubitemid 43096581)
25. Ayhan A, Gultekin M, Taskiran C, et al. The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experience. Am J Ostet Gynecol 2006; 194:49-56. (Pubitemid 43017774)
26. Chi DS, McCaughty K, Diaz JP, et al. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer 2006; 106:1933-9. (Pubitemid 43673208)
27. Kehoe S, Powell J, Wilson S, Woodman C. The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma. Br J Cancer 1994; 70:1014-7. (Pubitemid 24331106)
28. Junor EJ, Hole DJ, McNulty L, Mason M, Young J. Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br J Obstet Gynaecol 1999; 106:1130-6. (Pubitemid 29495411)